Harnessing machine learning-driven multiomics integration: deciphering programmed cell death networks for prognostication and immunotherapy prediction in lung adenocarcinoma
The PCD signature confers significant potential to predict prognosis of LUAD in patients, and NAPSA is promising as a new marker for predicting the efficacy of immunotherapy.
Authors
- Bin Luo (ORCID: https://orcid.org/0000-0003-1061-1019)
- youfang chen
- Wuguang Chang
- Zhesheng Wen
Institutions
- Sun Yat-sen University (CN)
- Fifth Affiliated Hospital of Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Cell Biology and Toxicology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1007/s10565-025-10125-4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00